Wealthfront Advisers LLC Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wealthfront Advisers LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 2,967 shares of the medical equipment provider’s stock after acquiring an additional 66 shares during the period. Wealthfront Advisers LLC’s holdings in Intuitive Surgical were worth $1,602,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Manchester Financial Inc. purchased a new position in Intuitive Surgical during the second quarter worth about $25,000. Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its stake in Intuitive Surgical by 733.3% during the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 66 shares during the last quarter. FNY Investment Advisers LLC bought a new stake in Intuitive Surgical during the second quarter worth about $47,000. North Star Investment Management Corp. bought a new stake in Intuitive Surgical during the third quarter worth about $49,000. Finally, Motco bought a new stake in Intuitive Surgical during the second quarter worth about $51,000. Institutional investors and hedge funds own 85.90% of the company’s stock.

In other news, VP Marshall Mohr sold 15,000 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $526.11, for a total value of $7,891,650.00. Following the completion of the sale, the vice president now owns 20,135 shares of the company’s stock, valued at approximately $10,593,224.85. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Salvatore Brogna sold 1,171 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $505.23, for a total value of $591,624.33. Following the completion of the sale, the chief operating officer now directly owns 5,933 shares of the company’s stock, valued at approximately $2,997,529.59. The disclosure for this sale can be found here. In the last three months, insiders sold 25,869 shares of company stock valued at $13,664,252. 1.70% of the stock is currently owned by corporate insiders.

ISRG has been the subject of several research analyst reports. BidaskClub lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, September 11th. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Friday, July 12th. Canaccord Genuity reaffirmed a “buy” rating and set a $610.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research note on Friday, July 19th. UBS Group set a $560.00 price target on Intuitive Surgical and gave the stock a “hold” rating in a research note on Friday, July 19th. Finally, Piper Jaffray Companies lifted their price target on Intuitive Surgical from $610.00 to $633.00 and gave the stock an “overweight” rating in a research note on Friday, July 19th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $575.33.

NASDAQ ISRG opened at $530.24 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $430.24 and a 1-year high of $589.32. The stock has a 50-day moving average of $519.88 and a 200-day moving average of $517.55. The firm has a market cap of $59.80 billion, a PE ratio of 55.87, a price-to-earnings-growth ratio of 3.81 and a beta of 1.13.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share for the quarter, beating analysts’ consensus estimates of $2.23 by $1.02. Intuitive Surgical had a return on equity of 17.35% and a net margin of 29.95%. The company had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the previous year, the company posted $2.76 EPS. Intuitive Surgical’s revenue for the quarter was up 20.9% on a year-over-year basis. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 10.12 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Read More: Differences Between Momentum Investing and Long Term Investing

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.